Release of (1→3)-β-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production

Artificial Organs

Volumn 27, Issue 8, 2003, Pages 728-735

  Ohata, Atsushi ^a   Usami, Makoto ^a   Horiuchi, Takashi ^b   Nagasawa, Koichi ^c   Kinoshita, Keiko ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

^c UNIVERSITY OF EAST ASIA   (Japan)

Author keywords

(1 3) D glucan; Blood product; Depth filter; Fungitec G test; IL 1 beta; TNF alpha

Indexed keywords

BANDPASS FILTERS; BIOACTIVITY; BLOOD; CELL CULTURE; CELLULOSE; POLYAMIDES; RAYON;

(1→3)-Β-D-GLUCAN; BLOOD PRODUCTS; CYTOKINE PRODUCTION; D-GLUCAN; DEPTH FILTER; FILTER EXTRACTS; FUNGITEC G TEST; IL-1 BETA; PROINFLAMMATORY CYTOKINES; TNF ALPHA;

MACROPHAGES;

BETA 1,3 GLUCAN; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CELL CULTURE; CONTROLLED STUDY; FILTER; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ESCHERICHIA COLI;

EID: 0042329647     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07137.x     Document Type: Article

References (15)

1. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H, Shimada K, Kawai T. Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20.
2. Kohno S, Mitsutake K, Maesaki S, Yasuoka A, Miyazaki T, Kaku M, Koga H, Hara K. An evaluation of serodiagnostic tests in patients with candidemia: (1→3)-β-D-glucan, mannan, candida antigen by Cand-Tec, and D-arabinitol. Microbiol Immunol 1993;37:207-12.
3. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1→3)-β-D-glucan in blood products and release of (1→3)-β-D-glucan from depth type membrane filters for blood processing. Transfusion 2002;42:1189-95.
4. Miyazaki T, Kohno S, Koga H, Kaku M, Mitsuoka K, Maesaki S, Yasuoka A, Hara K, Tanaka S, Tamura H. G test, a new direct method for diagnosis of Candida infection: Comparison with assay for beta-glucan and mannan antigen in a rabbit model of systemic candidiasis. J Clin Lab Anal 1992;6:315-8.
5. Pearson FC, Bohon J, Lee W, Bruszer G, Sagona M, Dawe R, Jakubowski G, Morrison D, Dinarello C. Comparison of chemical analyses of hollow-fiber dialyzer extracts. Artif Organs 1984;8:291-8.
6. Yamagami S, Yoshihara H, Kishimoto T, Sugimura T, Niwa M, Maekawa M. Cuprophan membrane induced interleukin I activity. Trans Am Soc Artif Intern Organs 1986;32:98-101.
7. Yoshioka T, Ikegami K, Ikemura K, Shiono S, Uenishi M, Sugimoto H, Sugimoto T. A study on Limulus amebocyte lysate (LAL) reactive material derived from dialyzers. Jpn J Surg 1989;19:38-41.
8. Ziegler Heitbrock HW, Thiel E, Futterer A, Herzog V, Wirtz A, Riethmuller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988;41:456-61.
9. Yoshida K, Nakajima M, Yamasaki M, Kitano Y, Niki Y, Ohsawa G, Matsushima T. Investigation of influence of hemodialysis membranes and factors associated with hemodialysis on serum (1→3)-β-D-glucan. Jpn J Infect 1998;72:245-8.
10. Ikemura K, Ikegami K, Shimazu T, Yoshioka T, Sugimoto T. False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J Clin Microbiol 1989;27:1965-8.
11. Suda M, Ohno N, Adachi Y, Yadomae T. Tissue distribution of intraperitoneally administered (1→3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice. J Pharmacobiodyn 1992;15:417-26.
12. Miura T, Ohno N, Miura NN, Shimada S, Yadomae T. Inactivation of a particle β-glucan by proteins in plasma and serum. Biol Pharm Bull 1997;20:1103-7.
13. Williams DL, Mueller A, Browder W. Glucan-based macrophage stimulators. A review of their anti-infective potential. Clin Immunother 1996;5:392-9.
14. Masihi KN, Madaj K, Hintelmann H, Gast G, Kaneko Y. Down-regulation of tumor necrosis factor-alpha, moderate reduction of interleukin-1beta, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan. Int J Immunopharmacol 1997;19:463-8.
15. Hoffman OA, Olson EJ, Limper AH. Fungal beta-glucans modulate macrophage release of tumor necrosis factor-alpha in response to bacterial lipopolysaccharide. Immunol Lett 1993;37:19-25.